Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Nora Bennani

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Current Treatment Options in Oncology|July 2, 2021
How to Sequence Therapies in Peripheral T Cell LymphomaKitsada Wudhikarn, N Nora Bennani
Cancer Treatment and Research|January 1, 2019
Tumor Microenvironment in T-Cell LymphomasN Nora Bennani, Stephen M Ansell
Blood Reviews|March 10, 2023
Nodal peripheral T-cell lymphoma: Chemotherapy-free management, are we there yet?Sharina C Macapagal, N Nora Bennani
Expert Review of Hematology|April 12, 2017
Lymphoma classification update: B-cell non-Hodgkin lymphomasManli Jiang, N Nora Bennani, Andrew L Feldman
Expert Review of Hematology|August 1, 2019
Update on the classification of T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasmsAkira Satou, N Nora Bennani, Andrew L Feldman
Expert Review of Hematology|January 31, 2017
Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasmsManli Jiang, N Nora Bennani, Andrew L Feldman
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|January 19, 2026
A Masked Intruder: Extranodal Natural Killer/T-Cell Lymphoma Mimicking Preseptal CellulitisShane A Fuentes, Gregory J Griepentrog, Rebecca L King, et al.
Journal of Cutaneous Pathology|April 14, 2019
Cutaneous lesions of angioimmunoblastic T-cell lymphoma: Clinical, pathological, and immunophenotypic featuresNaoki Oishi, Julio C Sartori-Valinotti, N Nora Bennani, et al.
Nutrition and Cancer|September 21, 2018
Low Plasma Omega-3 Fatty Acid Levels May Predict Inferior Prognosis in Untreated Diffuse Large B-Cell Lymphoma: A New Modifiable Dietary Biomarker?Gita Thanarajasingam, Matthew J Maurer, Thomas M Habermann, et al.
Blood Advances|February 26, 2021
Microbial dysbiosis is associated with aggressive histology and adverse clinical outcome in B-cell non-Hodgkin lymphomaCatherine S Diefenbach, Brandilyn A Peters, Huilin Li, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Current Treatment Options in Oncology|July 2, 2021
How to Sequence Therapies in Peripheral T Cell LymphomaKitsada Wudhikarn, N Nora Bennani
Cancer Treatment and Research|January 1, 2019
Tumor Microenvironment in T-Cell LymphomasN Nora Bennani, Stephen M Ansell
Blood Reviews|March 10, 2023
Nodal peripheral T-cell lymphoma: Chemotherapy-free management, are we there yet?Sharina C Macapagal, N Nora Bennani
Expert Review of Hematology|April 12, 2017
Lymphoma classification update: B-cell non-Hodgkin lymphomasManli Jiang, N Nora Bennani, Andrew L Feldman
Expert Review of Hematology|August 1, 2019
Update on the classification of T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasmsAkira Satou, N Nora Bennani, Andrew L Feldman
Expert Review of Hematology|January 31, 2017
Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasmsManli Jiang, N Nora Bennani, Andrew L Feldman
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|January 19, 2026
A Masked Intruder: Extranodal Natural Killer/T-Cell Lymphoma Mimicking Preseptal CellulitisShane A Fuentes, Gregory J Griepentrog, Rebecca L King, et al.
Journal of Cutaneous Pathology|April 14, 2019
Cutaneous lesions of angioimmunoblastic T-cell lymphoma: Clinical, pathological, and immunophenotypic featuresNaoki Oishi, Julio C Sartori-Valinotti, N Nora Bennani, et al.
Nutrition and Cancer|September 21, 2018
Low Plasma Omega-3 Fatty Acid Levels May Predict Inferior Prognosis in Untreated Diffuse Large B-Cell Lymphoma: A New Modifiable Dietary Biomarker?Gita Thanarajasingam, Matthew J Maurer, Thomas M Habermann, et al.
Blood Advances|February 26, 2021
Microbial dysbiosis is associated with aggressive histology and adverse clinical outcome in B-cell non-Hodgkin lymphomaCatherine S Diefenbach, Brandilyn A Peters, Huilin Li, et al.
Pageof 6